Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants

Recruiting now · Phase 1

Conditions studied: Pain

In brief

The purpose of the study is to evaluate the pharmacokinetics (PK) of suzetrigine (SUZ) and its active metabolite in breast milk of lactating female participants. In addition, the purpose is also to evaluate the relative infant dose (RID), safety and tolerability of SUZ and its active metabolite in lactating female participants.

Key facts

Study ID

NCT07378865

Run by

Vertex Pharmaceuticals Incorporated

People needed

12

Starts

2026-02-13

Expected to finish

2027-02-26

Last updated by the study team

2026-05-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

Where it is running

• ICON - Utah - Salt Lake City Office — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.